Gender-specific associations of depression with positive and negative symptoms in acute schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 5, 2007, Pages 1095-1100

  Müller, Matthias J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Calgary Depression Rating Scale; Depression in schizophrenia; Negative symptoms

Indexed keywords

ADULT; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL STUDY; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; POSITIVE AND NEGATIVE SYNDROME SCALE; SCHIZOPHRENIA; SCORING SYSTEM; SEX DIFFERENCE; SYMPTOM;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; DEPRESSION; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX CHARACTERISTICS;

EID: 34249319406     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.03.014     Document Type: Article

References (40)

1. Acosta F.J., Aguilar E.J., Cejas M.R., Gracia R., Cabellero-Hidalgo A., and Siris S.G. Are there subtypes of suicidal schizophrenia? A prospective study. Schizophr Res 86 (2006) 215-220
2. Addington D., Addington J., and Schissel B. A depression rating scale for schizophrenics. Schizophr Res 3 (1990) 247-251
3. Addington D., Addington J., and Patten S. Gender and affect in schizophrenia. Can J Psychiatry 41 (1996) 265-268
4. Addington D., Addington J., Patten S., Remington G., Moamai J., Labelle A., et al. Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia. J Clin Psychopharmacol 22 (2002) 20-25
5. Addington D.D., Azorin J.M., Falloon I.R., Gerlach J., Hirsch S.R., and Siris S.G. Clinical issues related to depression in schizophrenia: an international survey of psychiatrists. Acta Psychiatr Scand 105 (2002) 189-195
6. an der Heiden W., Konnecke R., Maurer K., Ropeter D., and Häfner H. Depression in the long-term course of schizophrenia. Eur Arch Psychiatry Clin Neurosci 255 (2005) 174-184
7. Angst J., Gamma A., Gastpar M., Lepine J.P., Mendlewicz J., and Tylee A. Gender differences in depression. Epidemiological findings from the European DEPRES I and II studies. Eur Arch Psychiatry Clin Neurosci 252 (2002) 201-209
8. In: Benkert O., and Hippius H. (Eds). Kompendium der Psychiatrischen Pharmakotherapie. 6th edition (2006), Springer, Heidelberg
9. Bozikas V.P., Kosmidis M.H., Anezoulaki D., Giannakou M., Andreou C., and Karavatos A. Impaired perception of affective prosody in schizophrenia. J Neuropsychiatry Clin Neurosci 18 (2006) 81-85
10. Collaborative Working Group on Clinical Trial Evaluations. Atypical antipsychotics for treatment of depression in schizophrenia and affective disorders. J Clin Psychiatry 59 Suppl 12 (1998) 41-45
11. Fialko L., Freeman D., Bebbington P.E., Kuipers E., Garety P.A., Dunn G., et al. Understanding suicidal ideation in psychosis: findings from the Psychological Prevention of Relapse in Psychosis (PRP) trial. Acta Psychiatr Scand 114 (2006) 177-186
12. Flaum M., and Andreasen N. The reliability of distinguishing primary versus secondary negative symptoms. Compr Psychiatry 36 (1995) 421-427
13. Goldstein J.M. Sex, hormones and affective arousal circuitry dysfunction in schizophrenia. Horm Behav 50 (2006) 612-622
14. Häfner H. Gender differences in schizophrenia. Psychoneuroendocrinology Suppl 2 (2003) 17-54
15. Hargreaves W.M.A., Zachary R., LeGouillon M., Binder R., and Reus V. Neuroleptic dose: a statistical model for analyzing historical trends. J Psychiatr Res 21 (1987) 199-214
16. Kane J. Commentary: consensus statement on negative symptoms. Schizophr Bull 32 (2006) 223-224
17. Kay S.R., Fiszbein A., and Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 13 (1987) 261-277
18. Killgore W.D., Oki M., and Yurgelun-Todd D.A. Sex-specific developmental changes in amygdala responses to affective faces. Neuroreport 12 (2001) 427-433
19. Kontaxakis V., Havaki-Kontaxaki B., Margariti M., Stamouli S., Kollias C., and Christodoulou G. Suicidal ideation in inpatients with acute schizophrenia. Can J Psychiatry 49 (2004) 476-479
20. Kumari V., Aasen I., and Sharma T. Sex differences in prepulse inhibition deficits in chronic schizophrenia. Schizophr Res 69 (2004) 219-235
21. Lacerda A.L., Hardan A.Y., Yorbik O., Venulapalli M., Prasad K.M., and Keshavan M.S. Morphology of the orbitofrontal cortex in first-episode schizophrenia: relationship with negative symptomatology. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 510-516
22. Leung A., and Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl 401 (2000) 3-38
23. Lindamer L.A., Bailey A., Hawthorne W., Folsom D.P., Gilmer T.P., Garcia P., et al. Gender differences in characteristics and service use of public mental health patients with schizophrenia. Psychiatr Serv 54 (2003) 1407-1409
24. *D study. J Affect Disord 87 (2005) 141-150
25. Mauri M., Volonteri L., De Gaspari I., Colasanti A., Brambilla M., and Cerruti L. Substance abuse in first-episode schizophrenic patients: a retrospective study. Clin Pract Epidemiol Mental Health 2 (2006) 4
26. Möller H.J. Antidepressive effects of traditional and second generation antipsychotics: a review of the clinical data. Eur Arch Psychiatry Clin Neurosci 255 (2005) 83-93
27. Müller M.J. Overlap between emotional blunting, depression, and extrapyramidal symptoms in schizophrenia. Schizophr Res 57 (2002) 307-309
28. Müller M.J., and Wetzel H. Dimensionality of depression in acute schizophrenia: a methodological study using the Bech-Rafaelsen Melancholia Scale (BRMS). J Psychiatr Res 32 (2000) 369-378
29. Müller M.J., Marx-Dannigkeit P., Schlösser R., Wetzel H., Addington D., and Benkert O. The Calgary Depression Rating Scale for Schizophrenia: development and interrater reliability of a German version (CDSS-G). J Psychiatr Res 33 (1999) 433-443
30. Müller M.J., Wetzel H., Szegedi A., and Benkert O. Three dimensions of depression in patients with acute psychotic disorders: a replication study. Compr Psychiatry 40 (1999) 449-457
31. Müller M.J., Szegedi A., Wetzel H., and Benkert O. Depressive factors and their relationships with other symptom domains in schizophrenia, schizoaffective disorder, and psychotic depression. Schizophr Bull 27 (2001) 19-28
32. Myin-Germeys I., Krabbendam L., Delespaul P.A., and van Os J. Sex differences in emotional reactivity to daily life stress in psychosis. J Clin Psychiatry 65 (2004) 805-809
33. National Institute of Mental Health (NIMH). 028 CGI. Clinical global impressions. In: Guy W. (Ed). EDCEU assessment manual for psychopharmacology. 2nd revised edition (1976), NIMH, Rockville, Maryland 217-222
34. Rocca P., Bellino S., Calvarese P., Marchiaro L., Patria L., Rasetti R., et al. Depressive and negative symptoms in schizophrenia: different effects on clinical features. Compr Psychiatry 46 (2005) 304-310
35. Salokangas R.K. Gender and the use of neuroleptics in schizophrenia. Schizophr Res 66 (2004) 41-49
36. Siris S.G. Depression in schizophrenia: perspective in the era of "atypical" antipsychotic agents. Am J Psychiatry 157 (2000) 1379-1389
37. Siris S.G., Addington D., Azorin J.M., Falloon I.R., Gerlach J., and Hirsch S.R. Depression in schizophrenia: recognition and management in the USA. Schizophr Res 47 (2001) 185-197
38. Sota T.L., and Heinrichs R.W. Sex differences in verbal memory in schizophrenia patients treated with "typical" neuroleptics. Schizophr Res 62 (2003) 175-182
39. Weiss E.M., Kohler C.G., Brensinger C.M., Bilker W.B., Loughead J., Delazer M., et al. Gender differences in facial emotion recognition in persons with chronic schizophrenia. Eur Psychiatry 22 (2007) 116-122
40. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64 (2003) 663-667